<DOC>
	<DOCNO>NCT02929524</DOCNO>
	<brief_summary>Randomized clinical trial , control , double-blind , parallel two-arm .</brief_summary>
	<brief_title>Intranasal Ketamine Sedative Venipuncture</brief_title>
	<detailed_description>Randomized , double-blind , placebo control study conduct Clinical Hospital Porto Alegre November / 15 August / 16 . This study approve Ethics Committee Institution . Participated child require venipuncture randomize intervention group receive ketamine IN 4 mg/kg placebo saline group . The group compare : Puncture time , ease nurse perform procedure , adverse event , change vital sign perception companion .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<criteria>Children hospitalize Pediatric Inpatient Units , presence legal guardian ; Aged 3 month 12 year ; Requiring venipuncture independent research . Severe neurological sequela ; Patients need immediate venipuncture risk ; Presence active nosebleed ; Patients use drug sedative analgesic continuo ; Children experience clinical change ketamine .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ketamine</keyword>
	<keyword>Intranasal administration</keyword>
	<keyword>Pediatric nursing</keyword>
</DOC>